The Pfizer mRNA Vaccine: Pharmacokinetics and Toxicity
The dangers of the COVID-19 vaccine spike protein and its interactions with the human immune system, conferring risks of clotting and leakage of blood vessels, are becoming increasingly well known. But how far and wide in the body can such dangers spread? What does that mean for vaccine safety?
And what of the vaccine lipid nanoparticle (LNP), composed of lipids that have never been injected into human beings before?
What does the existing evidence on vaccine pharmacokinetics, and the toxicity of its components, reveal? Why can the vaccines be expected to cause:
- blood clotting shortly after vaccination, potentially leading to heart attacks, stroke, and venous thrombosis
- grave harm to female fertility
- grave harm to breastfed infants
- cumulative toxicity after multiple injections?